Richard Amerling, MD
Director of Outpatient DialysisBETH ISRAEL MEDICAL CENTER INC
Member of the Healthcare Council
Richard Amerling, MD, is Director of Outpatient Dialysis and Continuous Renal Replacement Therapy at the Beth Israel Medical Center in New York City. Dr. Amerling has an extensive background in all aspects of consultative nephrology including hypertension, kidney stones, glomerular diseases, diabetes, renal biopsy, and acute and chronic renal failure. He has written extensively about health care economics and politics and has been published in the New York Times, The Wall Street Journal, Investor's Business Daily, The National Review, Internal Medicine News, The Dialysis Times, Nephrology News and Issues. (This is me - Update Profile)
| 1988 - present | Director of Outpatient Dialysis BETH ISRAEL MEDICAL CENTER INC |
|---|
GLG Study Groups with Richard Amerling, MD(?)
| Study Group Name | Members |
|---|---|
| Nephrologists (US) | 525 |
| Physicians who Perform Dialysis | 25 |
| Aranesp Prescribers for Red Blood Cell Disorders (US) | 52 |
| Physicians who Treat End Stage Renal Disease (ESRD) | 100 |
GLG NewsSM
Analyses by Richard Amerling, MD(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Richard Amerling, MD has not published any public GLG News analyses.
View all GLG News in Healthcare
View all GLG News in Healthcare
GLG InstituteSM Seminars with Richard Amerling, MD(?)
Richard Amerling, MD has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare
View all GLG InstituteSM Seminars in Healthcare
Request a project with Richard Amerling, MD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
40 of the leading 50
global mutual funds
global mutual funds
15 of the leading 20
global banks
global banks
8 of the leading 10
private equity firms
private equity firms
90%+ client subscription renewal rate

